Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel E Frigo

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Cancer Research|June 4, 2024
Diet and Tumor Genetics Conspire to Promote Prostate Cancer Metabolism and Shape the Tumor MicroenvironmentDaniel E Frigo
Endocrinology|December 4, 2020
Mitochondria in Metabolic Syndrome, Reproduction and Transgenerational Inheritance-Ongoing Debates and Emerging LinksElavarasan Subramani, Daniel E Frigo
Molecular Cancer Research : MCR|November 3, 2018
Regulation of SLC1A4 and SLC1A5 in Prostate Cancer-ResponseMark A White, Daniel E Frigo
Nature Reviews. Urology|February 8, 2017
A spatiotemporal hypothesis for the regulation, role, and targeting of AMPK in prostate cancerAyesha S Khan, Daniel E Frigo
Molecular Cancer Therapeutics|March 19, 2008
Differential effects of prostate cancer therapeutics on neuroendocrine transdifferentiationDaniel E Frigo, Donald P McDonnell
Essays in Biochemistry|November 26, 2021
Nuclear receptors: from molecular mechanisms to therapeuticsDaniel E Frigo, Maria Bondesson, Cecilia Williams
Steroids|November 21, 2017
Communication between genomic and non-genomic signaling events coordinate steroid hormone actionsSandi R Wilkenfeld, Chenchu Lin, Daniel E Frigo
Advances in Cancer Research|August 6, 2021
Roles of the tumor suppressor inhibitor of growth family member 4 (ING4) in cancerAymen Shatnawi, Dina I Abu Rabe, Daniel E Frigo
Carcinogenesis|June 20, 2015
miR-200a inhibits migration of triple-negative breast cancer cells through direct repression of the EPHA2 oncogeneEfrosini Tsouko, Jun Wang, Daniel E Frigo, et al.
Expert Opinion on Therapeutic Targets|January 21, 2015
Targeting the 5'-AMP-activated protein kinase and related metabolic pathways for the treatment of prostate cancerPetra Popovics, Daniel E Frigo, Andrew V Schally, et al.
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Cancer Research|June 4, 2024
Diet and Tumor Genetics Conspire to Promote Prostate Cancer Metabolism and Shape the Tumor MicroenvironmentDaniel E Frigo
Endocrinology|December 4, 2020
Mitochondria in Metabolic Syndrome, Reproduction and Transgenerational Inheritance-Ongoing Debates and Emerging LinksElavarasan Subramani, Daniel E Frigo
Molecular Cancer Research : MCR|November 3, 2018
Regulation of SLC1A4 and SLC1A5 in Prostate Cancer-ResponseMark A White, Daniel E Frigo
Nature Reviews. Urology|February 8, 2017
A spatiotemporal hypothesis for the regulation, role, and targeting of AMPK in prostate cancerAyesha S Khan, Daniel E Frigo
Molecular Cancer Therapeutics|March 19, 2008
Differential effects of prostate cancer therapeutics on neuroendocrine transdifferentiationDaniel E Frigo, Donald P McDonnell
Essays in Biochemistry|November 26, 2021
Nuclear receptors: from molecular mechanisms to therapeuticsDaniel E Frigo, Maria Bondesson, Cecilia Williams
Steroids|November 21, 2017
Communication between genomic and non-genomic signaling events coordinate steroid hormone actionsSandi R Wilkenfeld, Chenchu Lin, Daniel E Frigo
Advances in Cancer Research|August 6, 2021
Roles of the tumor suppressor inhibitor of growth family member 4 (ING4) in cancerAymen Shatnawi, Dina I Abu Rabe, Daniel E Frigo
Carcinogenesis|June 20, 2015
miR-200a inhibits migration of triple-negative breast cancer cells through direct repression of the EPHA2 oncogeneEfrosini Tsouko, Jun Wang, Daniel E Frigo, et al.
Expert Opinion on Therapeutic Targets|January 21, 2015
Targeting the 5'-AMP-activated protein kinase and related metabolic pathways for the treatment of prostate cancerPetra Popovics, Daniel E Frigo, Andrew V Schally, et al.
Pageof 8